Arzneiwerk AG VIDA (FRA:TLIK)
Germany
· Delayed Price · Currency is EUR 0.7100
-0.0150 (-2.07%)
At close: Jun 18, 2025, 10:00 PM CET
Arzneiwerk AG VIDA Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 0.24 | 0.21 | 59.28 | 73.37 | 2.52 | 2.82 | Upgrade
|
| Revenue Growth (YoY) | -99.46% | -99.65% | -19.21% | 2811.37% | -10.58% | -32.25% | Upgrade
|
| Cost of Revenue | -0 | 0 | 56.06 | 70.33 | 0.5 | 0.51 | Upgrade
|
| Gross Profit | 0.24 | 0.21 | 3.22 | 3.05 | 2.02 | 2.3 | Upgrade
|
| Selling, General & Admin | 0.15 | 0.17 | 2.17 | 2.8 | 1.48 | 1.63 | Upgrade
|
| Other Operating Expenses | 0.79 | 0.76 | 2.47 | 1.4 | 0.84 | 0.75 | Upgrade
|
| Operating Expenses | 0.94 | 0.94 | 5.65 | 20.74 | 2.34 | 2.4 | Upgrade
|
| Operating Income | -0.7 | -0.74 | -2.43 | -17.7 | -0.32 | -0.1 | Upgrade
|
| Interest Expense | -0.25 | -0.23 | -0.6 | -0.33 | -0 | -0.02 | Upgrade
|
| Interest & Investment Income | - | - | 0 | 0 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | 0 | 0.01 | -0 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.13 | 0.13 | 0 | 0 | 0.05 | - | Upgrade
|
| EBT Excluding Unusual Items | -0.81 | -0.84 | -3.02 | -18.02 | -0.27 | -0.11 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0 | 0.03 | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 1 | Upgrade
|
| Pretax Income | -0.81 | -0.84 | -3.02 | -17.99 | -0.27 | 0.89 | Upgrade
|
| Income Tax Expense | - | - | -0.14 | -1.05 | 0 | 0.06 | Upgrade
|
| Earnings From Continuing Operations | -0.81 | -0.84 | -2.88 | -16.94 | -0.27 | 0.82 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 0.31 | - | - | Upgrade
|
| Net Income | -0.81 | -0.84 | -2.88 | -16.64 | -0.27 | 0.82 | Upgrade
|
| Net Income to Common | -0.81 | -0.84 | -2.88 | -16.64 | -0.27 | 0.82 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -78.70% | Upgrade
|
| Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 | 4 | Upgrade
|
| Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 | 4 | Upgrade
|
| Shares Change (YoY) | - | - | - | - | 42.65% | 50.00% | Upgrade
|
| EPS (Basic) | -0.13 | -0.13 | -0.46 | -2.67 | -0.04 | 0.19 | Upgrade
|
| EPS (Diluted) | -0.13 | -0.13 | -0.46 | -2.67 | -0.04 | 0.19 | Upgrade
|
| EPS Growth | - | - | - | - | - | -85.80% | Upgrade
|
| Free Cash Flow | -0.63 | -0.86 | 0.07 | -0.69 | -0.33 | -1 | Upgrade
|
| Free Cash Flow Per Share | -0.10 | -0.14 | 0.01 | -0.11 | -0.05 | -0.23 | Upgrade
|
| Gross Margin | 100.00% | 99.96% | 5.44% | 4.15% | 80.19% | 81.78% | Upgrade
|
| Operating Margin | -293.85% | -355.57% | -4.10% | -24.12% | -12.72% | -3.39% | Upgrade
|
| Profit Margin | -340.94% | -403.46% | -4.86% | -22.68% | -10.62% | 29.26% | Upgrade
|
| Free Cash Flow Margin | -262.44% | -412.96% | 0.11% | -0.94% | -13.11% | -35.47% | Upgrade
|
| EBITDA | -0.7 | -0.73 | -1.71 | -1.55 | -0.29 | -0.08 | Upgrade
|
| EBITDA Margin | -291.32% | - | -2.88% | -2.11% | -11.59% | -2.70% | Upgrade
|
| D&A For EBITDA | 0.01 | 0.01 | 0.72 | 16.15 | 0.03 | 0.02 | Upgrade
|
| EBIT | -0.7 | -0.74 | -2.43 | -17.7 | -0.32 | -0.1 | Upgrade
|
| EBIT Margin | -293.85% | - | -4.10% | -24.12% | -12.72% | -3.39% | Upgrade
|
| Effective Tax Rate | - | - | - | - | - | 7.00% | Upgrade
|
| Revenue as Reported | 0.66 | 0.66 | - | - | - | 4.18 | Upgrade
|
Updated Dec 2, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.